Generics 49

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Bicalutamide manufacturers

49 products found

Filters

49 products found

bicalutamide

Tablets, film coated 50mg, 150mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16496
It is part of the Pharmaceutical and Medicine Manufacturing Industry and is located in the European market. The corporation makes over $6.00 million in revenue (USD). They specialize in urological goods, making them the first Spanish pharmaceutical laboratory to operate in the country with its facilities. Years later, the company introduced an allergic product range.

Manufacturer usually replies in 2 days

bicalutamide

Tablets, film coated 50mg, 150mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Portugal , Denmark , Ireland , Netherlands
Manufacturer #9438
A pharmaceutical manufacturer based in Europe that has been active in 10+ countries selling its products in Europe for 10+ years. Key production lines are Rx, OTC, dermo-cosmetics, and nutraceuticals. The main therapeutic areas include antibiotics.

Manufacturer usually replies in 6 days

bicalutamide

Tablets 150mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17195
It is a pharmaceutical firm based in Central Europe that has spent the last ten years focusing on the development, production, and distribution of specialty medications. Good Manufacturing Practices and Good Distribution Practices are met by the medications. Bioequivalence and bioavailability tests have validated the medications' safety and efficacy.

Manufacturer usually replies in 7 days

bicalutamide

Tablets 50mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17195
It is a pharmaceutical firm based in Central Europe that has spent the last ten years focusing on the development, production, and distribution of specialty medications. Good Manufacturing Practices and Good Distribution Practices are met by the medications. Bioequivalence and bioavailability tests have validated the medications' safety and efficacy.

Manufacturer usually replies in 7 days

bicalutamide

Tablets, film coated 50 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Registered in
Germany
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 10 days

bicalutamide

Tablets, film coated 50 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

bicalutamide

Tablets 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17557
It is a global pharmaceutical company that focuses on developing and marketing ethical products with great medical value for patients all over the world. They specialize in oncology, cardiology, and neurology-psychiatry, and their products are sold in 75 countries throughout the world.

Manufacturer usually replies in 15 days

bicalutamide

Tablets 50mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #3113

Manufacturer usually replies in 7 days

bicalutamide

Tablets 50mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
New Zealand
GMP approvals
EU GMP
Unavailable markets
Vietnam , Thailand , Malaysia , Hong Kong , Singapore , Australia , United States , Saudi Arabia , United Arab Emirates , Kuwait , Oman , Bahrain , Qatar
Manufacturer #12087
It is one of the largest privately-held pharmaceutical corporations in the world. They are tireless in their pursuit of improving healthcare outcomes for individuals all across the world. Every day, nearly 770 individuals collaborate, innovate, and grow with a firm that prioritizes people and encourages, develops, and challenges them to do their best job.

Manufacturer usually replies in 6 days

bicalutamide

Tablets 50 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
EU GMP
Manufacturer #12677

Manufacturer usually replies in 4 days

bicalutamide

Tablets, film coated 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

bicalutamide

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

bicalutamide

Tablets, film coated 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
WHO
Manufacturer #15160

Manufacturer usually replies in 5 days

bicalutamide

Tablets 50 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19670

Manufacturer usually replies in 8 days

bicalutamide

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

bicalutamide

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16454
A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

Manufacturer usually replies in 7 days

bicalutamide

Tablets 50 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #17453

Manufacturer usually replies in 8 days

bicalutamide

Tablets, film coated 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina, Brazil, Pakistan, Paraguay, Peru, Uruguay, WHO, PICS
Manufacturer #16112

Manufacturer usually replies in 6 days

bicalutamide

Tablets, film coated 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Guatemala
GMP approvals
Guatemala
Manufacturer #15114
A private company who have been in the market since the 1900s. A leading company with one of the fastest growth in terms of perspective. A leading pharmaceutical company that has innovativeness and affordable medical services at its core.

Manufacturer usually replies in 9 days

bicalutamide

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

Want to view all 49 products? Create your free account today!

BICALUTAMIDE

Bicalutamide is a hormone therapy. Its combination with gonadotropin-releasing hormone agonists like leuprolide or goserelin Bicalutamide is used to treat metastatic prostate cancer, a cancer that originates in the prostate and spreads to other parts of the body. Bicalutamide belongs to a family of drugs called nonsteroidal antiandrogens, that block the effect of androgen, the male hormone, which stops the growth and spread of cancer cells. It is classified as an "anti-androgen" and is often given in combination with "LHRH agonist," another type of hormone therapy. Bicalutamide is sold as Casodex® amongst other brand names. Imperial Chemical Industries (ICI) discovered Bicalutamide in the 1980s, and first patented it in 1982, following medical use in 1995. It was selected for development from a group of over 2,000 synthesized compounds. In the U.K. it was launched in 1995, it was subsequently approved for the treatment of prostate cancer.

Dosage Forms & Strengths

Bicalutamide is available in the form of a tablet. For treating Prostate cancer, the usual recommended adult dose is 50 mg in combination with LHRH analogue. In the treatment of Locally Advanced Prostate Cancer, the usual recommended adult dose is 150 mg a day as monotherapy.

The price of Bicalutamide

In the USA, consumers have to pay an average retail price of $133 for a supply of 30 tablets of 50mg strength.

How does Bicalutamide Works:

Hormones are chemical substances which are produced by glands in the body and enter the bloodstream and cause effects in other tissues. Male hormones called androgens (primary testosterone) stimulates prostate cancer. This cancer is treated through a hormone therapy, which works by reducing the amount of these hormones in a man with prostate cancer, eventually helping to fight the disease. Testosterone, produced by testicles is responsible for male characteristics like deepening voice and body hair. Hormone therapy works on the principle that receptors for specific hormones that are needed for cell growth are on the surface of tumor cells. This therapy thus aims to stop the production of hormones, block hormone receptors, or substitute chemically similar agents as the active hormone, making it unavailable for use by the tumor cell. Bicalutamide is an Antiandrogen, a substance that blocks the effects of testosterone. Prostate Cancer depends on the male hormone testosterone for its growth, so by reducing it, it is possible to slow down or shrink cancer.

Finding Bicalutamide Manufacturers and Suppliers

The best way to find and gain access to Bicalutamide manufacturers and Bicalutamide suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Bicalutamide can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier.
All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Bicalutamide to work with. You can fine-tune your search results using various filters too, letting you search for Bicalutamide from specific countries, for example.